Propranolol‐resistant infantile hemangioma successfully treated with sirolimus

VL Dávila‐Osorio, H Iznardo, E Roé, L Puig… - Pediatric …, 2020 - Wiley Online Library
VL Dávila‐Osorio, H Iznardo, E Roé, L Puig, E Baselga
Pediatric Dermatology, 2020Wiley Online Library
Infantile hemangiomas are the most common benign vascular tumors in childhood.
Propranolol is the first‐line treatment for infantile hemangiomas, but failures may occur.
Sirolimus, an mTOR inhibitor, is a promising drug for the treatment of vascular malformations
and vascular tumors. We present the case of a child with multiple infantile hemangiomasthat
was successfully treated with sirolimus and propranolol after failure of combined propranolol
and prednisolone treatment.
Abstract
Infantile hemangiomas are the most common benign vascular tumors in childhood. Propranolol is the first‐line treatment for infantile hemangiomas, but failures may occur. Sirolimus, an mTOR inhibitor, is a promising drug for the treatment of vascular malformations and vascular tumors. We present the case of a child with multiple infantile hemangiomasthat was successfully treated with sirolimus and propranolol after failure of combined propranolol and prednisolone treatment.
Wiley Online Library